Amyloidosis

• 

  Subject Areas on Research

  • A 27-year-old woman with cough, dyspnea, and wheezing. 
  • A cross-sectional study of patient-reported outcomes and symptom burden using PROMIS and PRO-CTCAE measures in light chain amyloidosis. 
  • A fatal case of constrictive pericarditis due to a marked, selective pericardial accumulation of amyloid. 
  • A molecular genetic study of intracerebral hemorrhage. 
  • A review of rectal biopsy. 
  • A tale of two diagnoses: The role of noninvasive cardiovascular imaging to differentiate cardiac amyloidosis 
  • Abdominal fat pad aspiration biopsy for tissue confirmation of systemic amyloidosis: specificity, positive predictive value, and diagnostic pitfalls. 
  • Acquired functional asplenia. Association with spontaneous rupture of the spleen and fatal spontaneous rupture of the liver in amyloidosis. 
  • Acquired, non-amyloid related factor X deficiency: review of the literature. 
  • Advanced glycation end products contribute to amyloidosis in Alzheimer disease. 
  • Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosis. 
  • Altered Nulling of Myocardium and Blood Pool. 
  • Amyloid deposition in the eyelids. 
  • Amyloid myopathy presenting with respiratory failure. 
  • Amyloid-β PET Scan Results Disclosure and Care-Partner Emotional Well-Being Over Time. 
  • Amyloidoma of the neck: case report and review of the literature. 
  • An approach to monoclonal gammopathies in the elderly. 
  • Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. 
  • Baseline Characteristics Predict the Presence of Amyloid on Endomyocardial Biopsy. 
  • Baseline patient-reported outcomes in light-chain amyloidosis patients enrolled on an interventional clinical trial. 
  • CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis. 
  • CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. 
  • Catheter ablation of atrial fibrillation in cardiac amyloidosis. 
  • Chronic myopathy due to immunoglobulin light chain amyloidosis. 
  • Clinical pathway to screen for cardiac amyloidosis in heart failure with preserved ejection fraction. 
  • Combination chemotherapy for primary amyloidosis reconsidered. 
  • Death during coronary angiography in a woman with cardiac amyloidosis. 
  • Development of a conceptual model of patient-reported outcomes in light chain amyloidosis: a qualitative study. 
  • Diagnosis of ocular surface lesions using ultra-high-resolution optical coherence tomography. 
  • Diffuse cystic lung disease at high-resolution CT. 
  • Dysarthria and dysphagia from light chain amyloidosis. 
  • Elevated urokinase-type plasminogen activator level and bleeding in amyloidosis: case report and literature review. 
  • Extraocular muscle involvement in idiopathic primary amyloidosis. 
  • Facial diplegia due to amyloidosis. 
  • Familial carpal tunnel syndrome. 
  • Gastrointestinal manifestations of amyloidosis. 
  • In vivo amyloid imaging in Alzheimer's disease. 
  • Livers from patients with apolipoprotein A-I amyloidosis are not suitable as "domino" donors. 
  • Localized amyloidosis of the upper urinary tract: a case series of three patients managed with reconstructive surgery or surveillance. 
  • Localized amyloidosis of the urethra: diagnostic implications and management. 
  • Localized conjunctival amyloidosis: case reports and review of literature. 
  • Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic. 
  • Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. 
  • Mice with alopecia, osteoporosis, and systemic amyloidosis due to mutation in Zdhhc13, a gene coding for palmitoyl acyltransferase. 
  • Multiple myeloma-associated amyloidosis and giant cell arteritis. 
  • Multiple myeloma. Clinical practice guidelines in oncology. 
  • Nodular pulmonary infiltrate in a patient with Sjögren's syndrome. 
  • Outcomes following cardioversion for patients with cardiac amyloidosis and atrial fibrillation or atrial flutter. 
  • Palpitations in a 64-year-old man. 
  • Peripheral polyneuropathy, high and low molecular weight IgM, and amyloidosis. 
  • Pinch Purpura: A Cutaneous Manifestation of Systemic Amyloidosis. 
  • Pleural amyloidosis. 
  • Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021. 
  • Primary amyloidosis, pure red cell aplasia, and Kaposi's sarcoma in a single patient. 
  • Primary systemic amyloidosis masquerading as giant cell arteritis. Case report and review of the literature. 
  • Pulmonary alveolar proteinosis. 
  • Rectal biopsy in carpal tunnel syndrome in amyloidosis. 
  • Red flags in cardiac amyloidosis. 
  • Regression of cardiac amyloidosis after stem cell transplantation assessed by cardiovascular magnetic resonance imaging. 
  • Renal Amyloidosis in Deficiency of Adenosine Deaminase 2: Successful Experience With Canakinumab. 
  • Renal involvement in type I glycogen storage disease. 
  • Resolution of primary amyloidosis during chemotherapy. Studies in a patient with nephrotic syndrome. 
  • Rheumatologic manifestations of cancer. 
  • Sequestration of amyloid beta-peptide. 
  • Sex-specific genetic predictors of Alzheimer's disease biomarkers. 
  • Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. 
  • The Role of Cardiac MR Imaging in the Assessment of Patients with Cardiac Amyloidosis. 
  • The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. 
  • Tuberous sclerosis complex is a novel, amyloid-independent tauopathy associated with elevated phosphorylated 3R/4R tau aggregation. 
  • Ultrasound Visualization and Recording of Transient Myocardial Vibrations. 
  • Understanding and recognizing cardiac amyloidosis. 
• 

  Keywords of People

  • Costa, Cristiana A., Assistant Professor of Medicine, Duke Cancer Institute